Loading...
Loading...
Genzyme, a Sanofi company
SNY and one of the world's
leading biotechnology companies, and Veracyte, Inc., a molecular diagnostics
company pioneering the emerging field of molecular cytology, today announced a
global co-promotion partnership to provide a comprehensive solution for
thyroid patients. The arrangement will give patients worldwide increased
access to an advanced personalized medicine solution for improved diagnosis of
thyroid nodules, and the potential to significantly reduce the number of
unnecessary thyroidectomies.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in